Citation Impact
Citing Papers
Activation of β-Catenin in Dendritic Cells Regulates Immunity Versus Tolerance in the Intestine
2010 Science
Where Wnts Went: The Exploding Field of Lrp5 and Lrp6 Signaling in Bone
2008
2012
DKK1 Antagonizes Wnt Signaling without Promotion of LRP6 Internalization and Degradation
2008
Adenomatous polyposis coli-mediated control of β-catenin is essential for both chondrogenic and osteogenic differentiation of skeletal precursors
2009
Noncanonical Wnt-4 Signaling Enhances Bone Regeneration of Mesenchymal Stem Cells in Craniofacial Defects through Activation of p38 MAPK
2007
Osteoporosis
2019 Standout
Analysis of multiple bone responses to graded strains above functional levels, and to disuse, in mice in vivo show that the human Lrp5 G171V High Bone Mass mutation increases the osteogenic response to loading but that lack of Lrp5 activity reduces it
2011
NF-κB signaling in inflammation
2017 Standout
The effects of Dickkopf-1 antibody on metaphyseal bone and implant fixation under different loading conditions
2011
Brown and beige fat: development, function and therapeutic potential
2013 Standout
Cancer to bone: a fatal attraction
2011 Standout
Intestinal homeostasis and its breakdown in inflammatory bowel disease
2011 StandoutNature
Knocking down dickkopf-1 alleviates estrogen deficiency induction of bone loss. A histomorphological study in ovariectomized rats
2006
Molecular mechanisms of epithelial–mesenchymal transition
2014 Standout
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
2012 Standout
Wnt signaling in cancer
2016 Standout
Targeting the Wnt/β-Catenin Pathway to Regulate Bone Formation in the Adult Skeleton
2007
Increased skeletal VEGF enhances β‐catenin activity and results in excessively ossified bones
2009
Chronic Inflammation (Inflammaging) and Its Potential Contribution to Age-Associated Diseases
2014 Standout
mTORC2 Promotes Tumorigenesis via Lipid Synthesis
2017
TGFβ signalling in context
2012 Standout
Activation of Gpr109a, Receptor for Niacin and the Commensal Metabolite Butyrate, Suppresses Colonic Inflammation and Carcinogenesis
2014 Standout
WNT signalling pathways as therapeutic targets in cancer
2012 Standout
Psychotropic drugs have contrasting skeletal effects that are independent of their effects on physical activity levels
2010
GSK-3β Controls Osteogenesis through Regulating Runx2 Activity
2007
Secreted and Transmembrane Wnt Inhibitors and Activators
2012
Cancer immunotherapy via dendritic cells
2012 Standout
Osteocytes, mechanosensing and Wnt signaling
2008
Hepatocellular carcinoma
2021 Standout
Control of Bone Mass and Remodeling by PTH Receptor Signaling in Osteocytes
2008
Fracture Risk From Psychotropic Medications
2008
A Rate-Limiting Role for Dickkopf-1 in Bone Formation and the Remediation of Bone Loss in Mouse and Primate Models of Postmenopausal Osteoporosis by an Experimental Therapeutic Antibody
2011
The Pathogenesis of Rheumatoid Arthritis
2011 Standout
Current Concepts of Follicle-Stimulating Hormone Receptor Gene Regulation1
2010
Osteoporosis: now and the future
2011 Standout
Dickkopf-1: a suitable target for the management of myeloma bone disease
2009
Indigenous Bacteria from the Gut Microbiota Regulate Host Serotonin Biosynthesis
2015 Standout
WNT signaling in bone homeostasis and disease: from human mutations to treatments
2013 Standout
Bone as a Target Organ in Rheumatic Disease: Impact on Osteoclasts and Osteoblasts
2015
PPARγ in bone homeostasis
2010
Synthesis, properties, and biomedical applications of gelatin methacryloyl (GelMA) hydrogels
2015 Standout
Body composition and sarcopenia: The next-generation of personalized oncology and pharmacology?
2018
Integrating Patterning Signals: Wnt/GSK3 Regulates the Duration of the BMP/Smad1 Signal
2007
Wnt/β-Catenin Signaling and Disease
2012 Standout
Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
2009 Standout
Graves' Ophthalmopathy
2010 Standout
Lrp5 Controls Bone Formation by Inhibiting Serotonin Synthesis in the Duodenum
2008
Wnt signaling as a therapeutic target for bone diseases
2009
Wnt inhibitory factor 1 is epigenetically silenced in human osteosarcoma, and targeted disruption accelerates osteosarcomagenesis in mice
2009
The Wnt Co-receptor LRP5 Is Essential for Skeletal Mechanotransduction but Not for the Anabolic Bone Response to Parathyroid Hormone Treatment
2006
Chronic cold exposure results in subcutaneous adipose tissue browning and altered global metabolism in Qinghai-Tibetan plateau pika (Ochotona curzoniae)
2018 StandoutNobel
Growth Differentiation Factor 11 Is a Circulating Factor that Reverses Age-Related Cardiac Hypertrophy
2013 Standout
Brown adipose tissue thermogenic adaptation requires Nrf1-mediated proteasomal activity
2018 StandoutNobel
Physiology and Pathophysiology of Purinergic Neurotransmission
2007 Standout
Suppression of Wnt Signaling by Dkk1 Attenuates PTH-Mediated Stromal Cell Response and New Bone Formation
2010
Sarcopenia
2019 Standout
Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone
2014 StandoutNature
Wnt/β-Catenin Signaling Is a Normal Physiological Response to Mechanical Loading in Bone
2006
The Binding Between Sclerostin and LRP5 is Altered by DKK1 and by High-Bone Mass LRP5 Mutations
2008
Regulation of bone mass by Wnt signaling
2006
Adaptive thermogenesis in adipocytes: Is beige the new brown?
2013
Suppression of bone formation by osteoclastic expression of semaphorin 4D
2011 Standout
Surrogate Wnt agonists that phenocopy canonical Wnt and β-catenin signalling
2017 StandoutNatureNobel
What We Talk About When We Talk About Fat
2014 Standout
The gut microbiota — masters of host development and physiology
2013 Standout
Modulation of Wnt signaling influences fracture repair
2010
Proteobacteria: microbial signature of dysbiosis in gut microbiota
2015 Standout
Adipocyte differentiation from the inside out
2006 Standout
Protective and pathogenic functions of macrophage subsets
2011 Standout
Cytokines in the pathogenesis of rheumatoid arthritis
2007 Standout
The Hallmarks of Aging
2013 Standout
Mechanical Stimulation of Bone in Vivo Reduces Osteocyte Expression of Sost/Sclerostin
2007
Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis
2012 Standout
Autonomic neural signals in bone: Physiological implications for mandible and dental growth
2004
Regulation of Early Adipose Commitment by Zfp521
2012
Neutralisation of Dkk-1 protects from systemic bone loss during inflammation and reduces sclerostin expression
2010
Dickkopf-1 is a master regulator of joint remodeling
2007
Negative Regulation of Bone Formation by the Transmembrane Wnt Antagonist Kremen-2
2010
Networks and hubs for the transcriptional control of osteoblastogenesis
2006
Loss-of-function of ACVR1 in osteoblasts increases bone mass and activates canonical Wnt signaling through suppression of Wnt inhibitors SOST and DKK1
2011
Update on Wnt signaling in bone cell biology and bone disease
2011
Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities
2017 Standout
miR-29 Modulates Wnt Signaling in Human Osteoblasts through a Positive Feedback Loop
2010
Inflammatory bone loss: pathogenesis and therapeutic intervention
2012 Standout
MECHANISMS IN ENDOCRINOLOGY: Genetics of human bone formation
2017
Brown Adipose Tissue in Adult Humans: A Metabolic Renaissance
2013
2014
Wnt/β-Catenin Signaling Is a Normal Physiological Response to Mechanical Loading in Bone
2006
The role of Dickkopf-1 in bone development, homeostasis, and disease
2008
Advances in engineering hydrogels
2017 StandoutScience
In Vivo Analysis of Wnt Signaling in Bone
2007
Treatment of Sarcopenia with Bimagrumab: Results from a Phase II, Randomized, Controlled, Proof‐of‐Concept Study
2017
PTH receptor signaling in osteocytes governs periosteal bone formation and intracortical remodeling
2010
Conditional Inactivation of Noggin in the Postnatal Skeleton Causes Osteopenia
2012
Lrp6 Hypomorphic Mutation Affects Bone Mass Through Bone Resorption in Mice and Impairs Interaction With Mesd
2008 StandoutNobel
Fat and Beyond: The Diverse Biology of PPARγ
2008 Standout
Osteoblast-Targeted Expression of Sfrp4 in Mice Results in Low Bone Mass
2007
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
Inhibiting Dickkopf-1 (Dkk1) Removes Suppression of Bone Formation and Prevents the Development of Osteolytic Bone Disease in Multiple Myeloma
2009
Essential Role of Wnt3a-Mediated Activation of Mitogen-Activated Protein Kinase p38 for the Stimulation of Alkaline Phosphatase Activity and Matrix Mineralization in C3H10T1/2 Mesenchymal Cells
2007
Wnt10b Inhibits Obesity in ob/ob and Agouti Mice
2007
Inhibiting Dickkopf-1 (Dkk1) Removes Suppression of Bone Formation and Prevents the Development of Osteolytic Bone Disease in Multiple Myeloma
2008
Antibody-based inhibition of DKK1 suppresses tumor-induced bone resorption and multiple myeloma growth in vivo
2006
Genetic identification of HSD-1, a conserved steroidogenic enzyme that directs larval development inCaenorhabditis elegans
2008 StandoutNobel
Targeted Disruption of the Wnt Regulator Kremen Induces Limb Defects and High Bone Density
2008
Hormones and Endocrine-Disrupting Chemicals: Low-Dose Effects and Nonmonotonic Dose Responses
2012 Standout
SOST and DKK: Antagonists of LRP Family Signaling as Targets for Treating Bone Disease
2010
Update in New Anabolic Therapies for Osteoporosis
2010
From Estrogen-Centric to Aging and Oxidative Stress: A Revised Perspective of the Pathogenesis of Osteoporosis
2010 Standout
Update on mitochondria and muscle aging: all wrong roads lead to sarcopenia
2018
Geometric cues for directing the differentiation of mesenchymal stem cells
2010 Standout
Bioactive Nanoengineered Hydrogels for Bone Tissue Engineering: A Growth-Factor-Free Approach
2015
Increased Sclerostin Serum Levels Associated with Bone Formation and Resorption Markers in Patients with Immobilization-Induced Bone Loss
2010
Advances in Male Contraception
2008
Production of Wnt Inhibitors by Myeloma Cells: Potential Effects on Canonical Wnt Pathway in the Bone Microenvironment
2007
Follistatin Targets Distinct Pathways To Promote Brown Adipocyte Characteristics in Brown and White Adipose Tissues
2017
Works of Frédéric Morvan being referenced
Lrp5-independent activation of Wnt signaling by lithium chloride increases bone formation and bone mass in mice
2005
Follicle-Stimulating Hormone Does Not Impact Male Bone Mass In Vivo or Human Male Osteoclasts In Vitro
2008
Zfp521 antagonizes Runx2, delays osteoblast differentiation in vitro, and promotes bone formation in vivo
2008
ATP Citrate Lyase Improves Mitochondrial Function in Skeletal Muscle
2015
Bone protection by estrens occurs through non–tissue-selective activation of the androgen receptor
2006
Chemical sympathectomy‐induced changes in TH‐, VIP‐, and CGRP‐immunoreactive fibers in the rat mandible periosteum: Influence on bone resorption
2003
An Antibody Blocking Activin Type II Receptors Induces Strong Skeletal Muscle Hypertrophy and Protects from Atrophy
2013
Absence of Estrogen Receptor-Related-α Increases Osteoblastic Differentiation and Cancellous Bone Mineral Density
2009
Deletion of a Single Allele of the Dkk1 Gene Leads to an Increase in Bone Formation and Bone Mass
2006
Blockade of the Activin Receptor IIB Activates Functional Brown Adipogenesis and Thermogenesis by Inducing Mitochondrial Oxidative Metabolism
2012